Professor, Medicine, Boston University School of Medicine
Cardiology
Dr. Emelia J. Benjamin, MD
|
|
Give Review
Emelia Benjamin practices Cardiology. She researched medicine at Case Western Reserve University School of Medicine. She over the years received 1 awards: "Fellow (FACC)". Doctor Emelia J. Benjamin, MD is a published doctor and has 101 publications published. The lastest was: 'Relations of circulating GDF-15, soluble ST2, and troponin-I concentrations with vascular function in the community: The Framingham Heart Study.' Dr. Emelia J. Benjamin is registered with Medicare.
Publications
- Circulating Adipokines and Vascular Function: Cross-Sectional Associations in a Community-Based Cohort.
- Atrial Flutter - Clinical Risk Factors and Adverse Outcomes in the Framingham Heart Study.
- Sex differences in platelet toll-like receptors and their association with cardiovascular risk factors.
- Low Cardiac Index is Associated with Incident Dementia and Alzheimer's Disease: The Framingham Heart Study.
- Association of soda consumption with subclinical cardiac remodeling in the Framingham Heart study.
- A 19-year-old female with tamponade and systemic lupus erythematosus (SLE).
- P-wave indices and atrial fibrillation: Cross-cohort assessments from the Framingham Heart Study (FHS) and Atherosclerosis Risk in Communities (ARIC) study.
- Left ventricular mechanical function: clinical correlates, heritability, and association with parental Heart failure.
- Relations of digital vascular function, cardiovascular risk factors, and arterial stiffness: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) cohort study.
- The relation of red blood cell fatty acids with vascular stiffness, cardiac structure and left ventricular function: The Framingham Heart Study.
- Global epidemiology of Atrial fibrillation.
- Components of Hemodynamic Load and Cardiovascular Events: The Framingham Heart Study.
- Familial Clustering of Mitral Valve Prolapse in the Community.
- Whole Blood Gene Expression and Interleukin-6 Levels.
- Plasma MicroRNAs are Associated with Atrial Fibrillation and Change after Catheter-ablation (the miRhythm Study).
- The Natural History of Left Ventricular Geometry in the Community: Clinical Correlates and Prognostic Significance of Change in LVÂ Geometric Pattern.
- Association of exome sequences with plasma C-reactive protein levels in >9000 participants.
- GWAS of Longevity in CHARGE Consortium Confirms APOE and FOXO3 Candidacy.
- Cross-Sectional Relations of Arterial Stiffness, Pressure Pulsatility, Wave Reflection, and Arterial Calcification.
- B-type natriuretic peptide and C-reactive protein in the prediction of Atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.
- Pleiotropic genes for metabolic Syndrome and inflammation.
- Forward and Backward Wave Morphology and Central Pressure Augmentation in Men and Women in the Framingham Heart Study.
- Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis.
- Relation of Long-Term Exposure to Air Pollution to Brachial Artery Flow-Mediated Dilation and Reactive Hyperemia.
- Assessing the incremental predictive performance of novel biomarkers over standard predictors.
- Novel trafficking-defective HCN4 mutation is associated with early-onset Atrial fibrillation.
- Large multiethnic Candidate Gene Study for C-reactive protein levels: identification of a novel association at CD36 in African Americans.
- Interleukin 1 receptor 1 and interleukin 1β regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans.
- Worldwide epidemiology of atrial fibrillation: a global burden of Disease 2010 study.
- Association of exhaled carbon monoxide with subclinical cardiovascular Disease and their conjoint impact on the incidence of cardiovascular outcomes.
- Relations between circulating microRNAs and Atrial fibrillation: Data from the Framingham Offspring Study.
- Novel Genetic Markers Associate with Atrial Fibrillation Risk in Europeans and Japanese.
- Clinical course of Atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke.
- Targeted sequencing in candidate genes for atrial fibrillation: the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Targeted Sequencing Study.
- Mild Expression of Mitral Valve Prolapse in the Framingham Offspring: Expanding the Phenotypic Spectrum.
- Left Ventricular Hypertrophy Patterns and Incidence of Heart Failure With Preserved Versus Reduced Ejection Fraction.
- Gene Expression and Genetic Variation in Human Atria.
- The Role of Arrhythmias in Defining Cardiac Dysfunction during Sepsis.
- Stroke Prevention in Atrial Fibrillation in Older Adults: Existing Knowledge Gaps and Areas for Innovation: A Summary of an American Federation for Aging Research Semi...
- Secular trends in echocardiographic left ventricular mass in the community: the Framingham Heart Study.
- Reproducibility of Speckle-Tracking-Based Strain Measures of Left Ventricular Function in a Community-Based Study.
- Relationship Among Circulating Inflammatory Proteins, Platelet Gene Expression, and Cardiovascular Risk.
- Thoracic periAortic and visceral adipose tissue and their cross-sectional associations with measures of vascular function.
- Reciprocal relations between physical disability, subjective health, and atrial fibrillation: The Framingham Heart Study.
- Projections on the number of individuals with Atrial fibrillation in the European Union, from 2000 to 2060.
- Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: incidence and risk factors.
- Multiple Inflammatory Biomarkers in Relation to Cardiovascular Events and Mortality in the Community.
- Genome-wide and Gene-Centric Analyses of Circulating Myeloperoxidase Levels in the CHARGE and CARe Consortia.
- Risk assessment for incident Heart failure in individuals with atrial fibrillation.
- Common genetic variation near the connexin-43 gene is associated with resting Heart rate in African Americans: A genome-wide association study of 13,372 participants.
- Aortic Root Remodeling and Risk of Heart Failure in the Framingham Heart Study.
- Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study.
- Early life predictors of Atrial fibrillation-related mortality: Evidence from the health and retirement study.
- Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study.
- Common values in assessing health outcomes from Disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.
- Relation of Circulating Liver Transaminase Concentrations to Risk of New-Onset Atrial Fibrillation.
- Outcomes of Medicare beneficiaries undergoing catheter ablation for Atrial fibrillation.
- Completion of Guideline-Recommended Initial Evaluation of Atrial Fibrillation.
- Aortic stiffness, blood pressure progression, and incident hypertension.
- An update on the prognosis of patients with Atrial fibrillation.
- Meta-analysis identifies six new susceptibility loci for Atrial fibrillation.
- Incidence and prevalence of Atrial fibrillation and associated mortality among medicare beneficiaries, 1993-2007.
- Plasma resistin, adiponectin, and risk of incident Atrial fibrillation: The Framingham Offspring Study.
- AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update A Guideline From the Americ...
- Next Steps in Cardiovascular Disease Genomic Research--Sequencing, Epigenetics, and Transcriptomics.
- White Blood Cell Count and Risk of Incident Atrial Fibrillation (From the Framingham Heart Study).
- Incident Stroke and Mortality Associated With New-Onset Atrial Fibrillation in Patients Hospitalized With Severe Sepsis.
- AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update: A Guideline From the Ameri...
- Atrial fibrillation: current knowledge and future directions in epidemiology and genomics.
- Circulating angiogenic cell populations, vascular function, and arterial stiffness.
- Association of Variation at the ABO Locus with Circulating Levels of sICAM-1, sP-selectin and sE-selectin: A Meta-Analysis.
- Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary Heart disease: meta-analysis of genome-wide asso...
- Insulin Resistance and Atrial Fibrillation (from the Framingham Heart Study).
- Vitamin D status is not related to development of Atrial fibrillation in the community.
- Relation of Left Ventricular Ejection Fraction to Cognitive Aging (from the Framingham Heart Study).
- Large-Scale Candidate Gene Analysis in Whites and African-Americans Identifies IL6R Polymorphism in Relation to Atrial Fibrillation: The NHLBI CARe Project.
- Early-Life Antecedents of Atrial Fibrillation: Place of Birth and Atrial Fibrillation-Related Mortality.
- A genome-wide association study of aging.
- Inflammatory Markers and Neuropsychological Functioning: The Framingham Heart Study.
- American Heart Association Atrial Fibrillation Research Summit: A Conference Report From the American Heart Association.
- Cardiac Dysfunction and Noncardiac Dysfunction as Precursors of Heart Failure With Reduced and Preserved Ejection Fraction in the Community.
- Atrial fibrillation and death after myocardial infarction: risk marker or causal mediator?
- Genome-Wide Association Analysis of Soluble ICAM-1 Concentration Reveals Novel Associations at the NFKBIK, PNPLA3, RELA, and SH2B3 Loci.
- Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american Heart association.
- P wave duration and risk of longitudinal atrial fibrillation in Persons ≥ 60 years old (from the Framingham Heart Study).
- Lack of replication in polymorphisms reported to be associated with Atrial fibrillation.
- Relation of brachial and digital measures of vascular function in the community: the Framingham Heart study.
- Relations of Circulating Resistin and Adiponectin and Cardiac Structure and Function: The Framingham Offspring Study.
- Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels.
- A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with Atrial fibrillation.
- Dietary factors and incident atrial fibrillation: the Framingham Heart Study.
- P wave duration is associated with cardiovascular and all-cause mortality outcomes: the National Health and Nutrition Examination Survey.
- A systematic assessment of causes of death after Heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction.
- Genome-wide association study of coronary Heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project.
- Association of matrix metalloproteinases with MRI indices of brain ischemia and aging.
- Familial aggregation of left ventricular geometry and association with parental Heart failure: the Framingham Heart Study.
- A multi-marker approach to predict incident CKD and microalbuminuria.
- Cardiovascular epigenetics: basic concepts and results from animal and human studies.
- Relations of circulating GDF-15, soluble ST2, and troponin-I concentrations with vascular function in the community: The Framingham Heart Study.
Schools
Case Western Reserve University School of Medicine
Boston City Hospital
University Hospital
Brigham and Women39s Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Brigham and Women's Hospital -
Boston University Medical Center -
Case Western Reserve University School of Medicine
Hospital
-
Boston Medical Center
Drug Facts
| NPI NUMBER | 1114902582 | |
| NPPES Provider LastName | BENJAMIN | |
| NPPES Provider FirstName | EMELIA | |
| NPPES Provider ZIPCode | 021182309 | |
| NPPES Provider State | MA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 45.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1114902582 |
| Last Name Of The Provider | BENJAMIN |
| First Name Of The Provider | EMELIA |
| View All |
Similar Doctors
|
|
Dr. Ami B. Bhatt, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew Huvos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rajeev L. Narayan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amil M. Shah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Andrew B. McCann, MB BS |
|
|
Dr. Kevin J. Croce, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward T. Carreras, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert P. Giugliano, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Dominic J. Allocco, MD |
|
|
Dr. Jan M. Pattanayak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marc P. Bonaca, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles I. Haffajee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ivan Luptak Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert A. Levine, MD |